Researchers publish the first comprehensive, 3D analysis of the complete rhabdomyosarcoma genome
In a paper published in NAR Cancer, researchers from the Center for Childhood Cancer Research at Nationwide Children's and their ...
Jun 14, 2023
Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors
In a new report in Science Advances, Sara G. Danielli and an international, interdisciplinary team of scientists at the department of ...
Feb 23, 2023
Blood tests could offer smarter treatment for children’s cancer
A simple blood test could help guide the treatment of children with the cancer rhabdomyosarcoma, a new study reports. Read more:...
Oct 21, 2022
Gene That Causes Deadliest Brain Tumor Also Causes Childhood Cancer
A gene that UVA Health researchers discovered is responsible for the deadliest type of brain tumor is also responsible for two forms of...
Jul 28, 2022
Study reveals a new therapeutic target for aggressive type of rhabdomyosarcoma
Scientists at St. Jude Children’s Research Hospital have identified an Achilles’ heel in rhabdomyosarcoma driven by a gene fusion ...
Jul 14, 2022
Research reveals a therapeutic opportunity to prevent rhabdomyosarcoma recurrence
Scientists at St. Jude Children's Research Hospital studied the population of cells that persists after therapy, causing ...
May 2, 2022
FDA Approves Rare Pediatric Disease Designation for IMX-110 for Rhabdomyosarcoma
Officials with the FDA have approved a Rare Pediatric Disease Designation for IMX-110 for the treatment of pediatric patients with ...
Jan 19, 2022
Genetic discovery could help guide treatment for aggressive childhood cancer
A new study could lead to improved decision making in assigning treatments for children with the aggressive cancer rhabdomyosarcoma ...
Jun 28, 2021
UA targeting rhabdomyosarcoma, a rare pediatric cancer with few treatment options
Rhabdomyosarcoma (RMS) is a rare cancer of the skeletal muscle that primarily affects pediatric patients. After diagnosis, about 3 out of...
Nov 1, 2018
Integrated analysis finds vulnerabilities to target in a high-risk pediatric tumor
St. Jude Children's Research Hospital investigators have completed the most comprehensive analysis yet of a common pediatric solid tumor,...
Aug 27, 2018